DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. It produces active pharmaceutical ingredients, including propofol, streptokinase, and teicoplanin; disposable syringes; and pills, capsules, and ointments, as well as small volume parentral, large volume parentral, and lyophilized injectable drug injections. The company also offers Teicon, Durakinase, and Lorelin Depot injections; produces various natural product materials, such as black cohosh extract and magnolia extract comprises ETIZM and TECA; and natural herb medicines. In addition, it provides general and prescription-based drugs; medical devices; ETC and cosmetic products; and quasi drugs that include lipossol hydrocare bandage. DongKook Pharmaceutical Co., Ltd. also exports its products to approximately 40 countries, including Japan, Europe, Central and South America, and India. The company was formerly known as UEC & Co., Ltd. and changed its name to DongKook Pharmaceutical Co., Ltd. in March 1982. DongKook Pharmaceutical Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea.
DongKook Pharmaceutical Dividend Announcement
• DongKook Pharmaceutical announced a annually dividend of ₩180.00 per ordinary share which will be made payable on 2024-04-19. Ex dividend date: 2023-12-27
• DongKook Pharmaceutical annual dividend for 2023 was ₩180.00
• DongKook Pharmaceutical's trailing twelve-month (TTM) dividend yield is 1.1%
• DongKook Pharmaceutical's payout ratio for the trailing twelve months (TTM) is 13.48%
DongKook Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2023-12-27 | ₩180.00 | annually | 2024-04-19 |
2022-12-28 | ₩180.00 | annually | 2023-04-21 |
2016-12-28 | ₩2000.00 | annually | |
2015-12-29 | ₩1500.00 | annually | |
2014-12-29 | ₩1500.00 | annually | |
2013-12-27 | ₩1400.00 | annually | |
2012-12-27 | ₩1900.00 | annually | |
2011-12-28 | ₩1900.00 | annually | |
2010-12-29 | ₩1900.00 | annually | |
2009-12-29 | ₩1500.00 | annually | |
2008-12-29 | ₩487.50 | annually | |
2007-12-27 | ₩533.00 | annually |
DongKook Pharmaceutical Dividend per year
DongKook Pharmaceutical Dividend growth
DongKook Pharmaceutical Dividend Yield
DongKook Pharmaceutical current trailing twelve-month (TTM) dividend yield is 1.1%. Interested in purchasing DongKook Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
DongKook Pharmaceutical Financial Ratios
DongKook Pharmaceutical Dividend FAQ
Other factors to consider when evaluating DongKook Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy DongKook Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: DongKook Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, DongKook Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, DongKook Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from DongKook Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: DongKook Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, DongKook Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: DongKook Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of DongKook Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review DongKook Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.